FDA Inspection 1160059 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on November 19, 2021 in St Petersburg, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 19, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- St Petersburg, FL (United States)